Paul Spence Jr. - 21 Feb 2025 Form 4 Insider Report for OptiNose, Inc. (OPTN)

Role
Chief Commercial Officer
Signature
/s/ Anthony J. Krick, Attorney-in-Fact
Issuer symbol
OPTN
Transactions as of
21 Feb 2025
Net transactions value
$0
Form type
4
Filing time
26 Feb 2025, 19:57:12 UTC
Previous filing
29 Feb 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPTN Common Stock Award $0 +17,025 +101% $0.000000 33,870 21 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPTN Stock Option (Right to Buy) Award $0 +8,525 $0.000000 8,525 21 Feb 2025 Common Stock 8,525 $5.77 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of restricted stock units (RSUs). Twenty-five percent (25%) of the RSUs vest on February 21, 2026, and the balance vests in equal quarterly installments over the remaining three years of the four year period, subject to continued service with the Issuer. Each RSU represents the right to receive one share of common stock of OptiNose, Inc.
F2 The option vests and becomes exercisable over a four-year period commencing on February 21, 2025. Twenty-five percent (25%) of the option vests and becomes exercisable on February 21, 2026, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer.

Remarks:

All share numbers reflect the 1-for-15 reverse stock split effected by the Company on December 30, 2024.